Champions Oncology, Inc.

NASDAQ:CSBR

Biotechnology

Healthcare
$4.44 -1.17%

-$0.08 today

Market cap
$61.80M
Beta
0.40
P/E (TTM)
-41.0
EPS (TTM)
-$0.16
52W Low $5.50High $9.63

Volume 0.01M

Average 0.01M

Balance Sheet

Inspect the capital base behind the business.

Assets

$32.34M

FY 2025 · Annual

+23.8% YoY

Liabilities

$28.57M

FY 2025 · Annual

+1.9% YoY

Equity

$3.77M

FY 2025 · Annual

Balance Sheet

USD
Metric
FY2021
Apr 2021
FY2022
Apr 2022
FY2023
Apr 2023
FY2024
Apr 2024
FY2025
Apr 2025
Cash & Equivalents4.69M9.01M10.12M2.62M9.79M
Short-term Investments00000
Net Receivables6.99M9.51M8.01M9.53M11.23M
Inventory00000
Other Current Assets001.33M1.5M1.35M
Total Current Assets12.63M19.66M19.46M13.64M22.37M
Property, Plant & Equipment (Net)14.61M15.36M14.5M11.97M9.46M
Goodwill335K335K335K335K335K
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets15K15K15K185K185K
Total Non-current Assets14.96M15.71M14.85M12.49M9.98M
Total Assets27.59M35.38M34.31M26.13M32.34M
Account Payables1.89M2.87M5.33M5.8M4.25M
Short-term Debt00000
Tax Payables00000
Deferred Revenue6.26M11.07M12.78M12.09M15.44M
Other Current Liabilities072K145K150K135K
Total Current Liabilities11.2M17.48M21.73M21.54M23.85M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities181K391K551K401K85K
Total Non-current Liabilities8.96M8.8M7.94M6.49M4.72M
Total Liabilities20.16M26.28M29.68M28.04M28.57M
Common Stock13K14K14K14K14K
Retained Earnings(72.53M)(71.98M)(77.32M)(84.59M)(79.89M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity7.43M9.1M4.64M(1.9M)3.77M
Total Debt9.6M9.47M8.6M7.43M6.11M
Net Debt4.91M459K(1.52M)4.81M(3.68M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$7.1M
Receivables$12.1M
Other Current$991.0K
Total Current Assets$20.2M
PP&E (Net)$9.3M
Goodwill$335.0K
Other Non-current-$1.3M
Total Non-current Assets$8.3M
Total Assets$28.4M

Analysis

Selected assets total $28.4M for Latest. The largest visible component is Receivables at $12.1M, about 42.4% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 9, 2026
4Statement of changes in beneficial ownershipNov 9, 2026
4Statement of changes in beneficial ownershipNov 9, 2026
4Statement of changes in beneficial ownershipNov 9, 2026
8-KCurrent reportOct 16, 2026

How much cash does CSBR have?

Champions Oncology, Inc. (CSBR) reported $9.79M in cash and equivalents in fiscal 2025.

How much debt does CSBR carry?

Champions Oncology, Inc. (CSBR) reported $6.11M of total debt, with net debt of -$3.68M.